

1,402,022 filings since 2004 · latest accepted Nov 4, 2026, 7:13 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Jun 23, 2025 accepted 8:00 AM ET | AYTUAYTU BIOPHARMA, INC | 1.01Material agreement2.03New debt obligation7.01Reg FD disclosure | DocumentSEC ↗ |
Jun 18, 2024 accepted 8:05 AM ET | AYTUAYTU BIOPHARMA, INC |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
1.01Material agreement2.03New debt obligation7.01Reg FD disclosure8.01Other events |
| DocumentSEC ↗ |
Mar 27, 2023 accepted 4:14 PM ET | AYTUAYTU BIOPHARMA, INC | 1.01Material agreement2.03New debt obligation | DocumentSEC ↗ |
Jan 31, 2022 accepted 8:20 AM ET | AYTUAYTU BIOPHARMA, INC | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale7.01Reg FD disclosure | DocumentSEC ↗ |
Mar 22, 2021 accepted 6:19 AM ET | AYTUAYTU BIOPHARMA, INC | 1.01Material agreement2.01Acquisition / disposition2.03New debt obligation5.02Officer / director change5.03Bylaws / fiscal year5.07Shareholder vote8.01Other events | DocumentSEC ↗ |
Nov 4, 2019 accepted 9:06 AM ET | AYTUAYTU BIOPHARMA, INC | 1.01Material agreement2.01Acquisition / disposition2.03New debt obligation3.02Unregistered equity sale5.03Bylaws / fiscal year7.01Reg FD disclosure | DocumentSEC ↗ |
Sep 2, 2015 accepted 8:23 AM ET | AYTUAYTU BIOPHARMA, INC | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Aug 12, 2015 accepted 9:25 AM ET | AYTUAYTU BIOPHARMA, INC | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Jul 24, 2015 accepted 8:00 AM ET | AYTUAYTU BIOPHARMA, INC | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |